P-选择素与冠状动脉疾病关系的研究进展
摘要
本文综述了 P-选择素与冠状动脉粥样硬化疾病关系近几年的研究进展。包括:P-选择素与冠状动脉粥样斑块的形成,与冠状动脉粥样斑块的不稳定性以及与血栓的形成;P-选择素与冠状动脉疾病临床表现;抗 P-选择素的治疗。
出处
《国外医学(老年医学分册)》
2005年第1期15-20,共6页
Foreign Medical Sciences(Geriatrics)
基金
湖南省自然科学基金(04JJ3106)
参考文献32
-
1陈宇杰,陆信武,蒋米尔.P-选择素与动脉粥样硬化形成[J].国外医学(生理病理科学与临床分册),2002,22(4):323-325. 被引量:7
-
2马晶茹,胡健.P-选择素与心血管病的研究进展[J].沈阳医学院学报,2003,5(1):55-56. 被引量:4
-
3Shebuski RJ, Kilgore KS. Role of inflammatory mediators in thrombogenesis. J Pharmacol Exp Ther, 2002; 300(3): 729-735.
-
4Evangelism V, Manarini S, Sideri R et al. Platelet/polymorphonuclear leukocyte interaction: P - selectin triggers protein- tyrosine phosphorylation- dependent CD11b/CD18 adhesion: Role of PSGL- 1 as a signaling molecule.Blood, 1999; 93 (3): 876-885.
-
5Frenette PS, Denis CV, Weiss L,et al. P - selectin glycoprotein ligand 1 (PSGL-1) is expressed cn platelets and can mediate platelet - endothelial interactions in vivo. J Exp Med, 2000; 191:1413-1422.
-
6Carter AM, Anagnostopoulou K, Mansfield MW et al.Soluble P- selectin levels, P - selectin polymorphisms and cardiovascular disease. J Thromb Hamaost, 2003; 1 (8) :1718- 1723.
-
7Barbaux SC, BlankenbergS, Rupprecht HJ et al. Association between P- selectin gene polymorphisms and soluble P-selectin levels and their relation to coronary artery disease. Arterioscler Thromb Vasc Biol, 2001; 21 (10):1668- 1673.
-
8Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res, 2001; 89 (9): 763-771.
-
9Dong ZM, Brown AA, Wagner DD. Prominent role of P-selectin in the development of advance atherosclerosis in apoE- deficient mice. Circulation, 2000; 101:2290-2295.
-
10Phillips JW, Barringhaus KG, Sanders JM et al. Single injection of P - selectin or P- selectin glycoprotein ligand -1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E- deficient mice. Circulation, 2003; 107 (17): 2244-2249.
二级参考文献24
-
1金佰泉.细胞和分子免疫学[M].西安:世界图书出版公司,1995.42-43.
-
2Shimomura H, Ogawa H, Arai H, et al. Serial changes in plasma levels of soluble P-selectin in patients with acute myocardial infarction[J]. Am J Cardiol, 1998, 81(4): 397-400.
-
3Ridker PM, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events[J]. Circulation, 2001, 103(4): 491 - 495.
-
4Murohara T, Parkinson SJ, Waldman SA, et al. Inhibition of nitric oxide biosynthesis promotes P-selectin expression in platelets. Role of protein kinase C[J]. Arterioscler Thromb Vasc Biol, 1995, 15(1): 2068-2075.
-
5Murohara T, Scalia R, Lefer AM. Lysophosphatidylcholine promotes Pselectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors[J] . Circ Res, 1996, 78(5): 780 - 789.
-
6Khew-Goodall Y, Wadham C, Stein BN, et al. Stat6 activation is essential for interleukin-4 induction of P-selectin transcription in human umbilical vein endothelial cells [J]. Arterioscler Thromb Vasc Biol,1999, 19(6): 1421-1429.
-
7Nomura S, Shouzu A, Omoto S, et al. Effect of cilostazol on soluble adhesion molecules and platelet-derived microparticles in patients with diabetes[J] .Thromb Haemost, 1998, 80(3):388 - 392.
-
8Lee CS, Choi JM, Pak DH, et al. Inhibition of expression of P-selectin by antioxidant in cholesterol-fed rats[J]. J Korean Med Sci, 1999, 14(1):8-14.
-
9Li LX, Chen JX, Liao DF, et al. Probucol inhibits oxidized-low density lipoprotein-induced adhesion of monccytes to endothelial cells by reducing P-selectin synthesis in vitro[J]. Endothelium, 1998, 6(1): 1-8.
-
10Xie X, Rivier AS, Zakrzewicz A, et al. Inhibition of selectin-mediated cell adhesion and prevention of acute inflammation by nonanticoagulant sulfated saccharides. Studies with carboxyl-reduced and sulfated heparin and with trestatin a sulfate[J]. Biol Chem, 2000, 275(44): 34818-34825.
共引文献9
-
1李二娃,范文兵,魏云红.P-选择素在急性冠脉综合征中的研究进展[J].内蒙古医学院学报,2006,28(S1):136-138. 被引量:1
-
2申艳慧,安冬青,唐欣荣.冠心病秽浊痰阻证与血浆P-选择素及血栓素B_2的相关性研究[J].四川中医,2013,31(8):71-72. 被引量:2
-
3李创鹏,彭敏,刘培中.炙甘草汤对PTCA术后心律失常P选择素内皮素CRP影响临床研究[J].中医药学刊,2006,24(4):655-656. 被引量:12
-
4徐爱妮,宋玲莉,王美丽.代谢综合征合并冠心病患者血浆P-选择素浓度的变化[J].心血管康复医学杂志,2009,18(4):343-345.
-
5李郁金,马宝花,孙平,尹作民.代谢综合征的早期干预指标及其临床价值[J].中国医刊,2010,45(7):48-50. 被引量:4
-
6雷明明,孙健,王琦,姚凤臣.不同剂量瑞舒伐他汀钙片对急诊行经皮冠状动脉介入的急性前壁心梗患者超敏C反应蛋白、P选择素及肿瘤坏死因子-α的影响[J].中国老年学杂志,2016,36(3):594-596. 被引量:26
-
7肖智谦,龙运玲,彭湘南,李其旺.P-选择素水平对不稳定心绞痛患者MACE发生率的影响[J].广西医科大学学报,2018,35(5):693-695. 被引量:3
-
8岳孟孟,李雪莹,赵迎春,张瑜.P-选择素及P-选择素糖蛋白配体-1基因多态性与缺血性脑血管病关系的研究进展[J].医学综述,2019,25(24):4919-4923. 被引量:5
-
9王开森,刘春兰,余红敏.血浆P-选择素测定对微血管病变的诊断价值[J].实用医药杂志,2004,21(2):124-125.
-
1张坡,张苗青.P-选择素在冠心病中的研究进展[J].国际内科学杂志,2007,34(7):432-434. 被引量:3
-
2胡高频,张文秀,李志梁.P-选择素与心肌缺血再灌注损伤[J].国外医学(心血管疾病分册),2001,28(1):26-29. 被引量:16
-
3季宪飞,黄亮.P-选择素与急性肺损伤[J].国外医学(内科学分册),2004,31(7):292-295. 被引量:3
-
4张剑青,刘鹏飞,王晨霞.P-选择素在冠心病中的研究新进展[J].包头医学,2008,32(3):155-157. 被引量:2
-
5陈宇杰,陆信武,蒋米尔.P-选择素与动脉粥样硬化形成[J].国外医学(生理病理科学与临床分册),2002,22(4):323-325. 被引量:7
-
6赵益明,朱明清,何杨,沈文红,阮长耿.抗P-选择素单抗的荧光素标记及其临床应用[J].中国病理生理杂志,2000,16(12):1289-1291. 被引量:6
-
7李美瑜,纪丽景,杨莉,胡广全,谢佳佳,蔡晶晶,吴爵非,刘俭,宾建平.携抗P-选择素单抗靶向微泡在炎症模型微循环中黏附机制及行为方式的研究[J].中华超声影像学杂志,2010,19(6):532-535. 被引量:2
-
8林丽娥,姚红霞,王述文,杨剑国.血小板特异性抗体、血小板相关抗体、网织血小板联合检测对血小板减少的鉴别诊断[J].血栓与止血学,2007,13(5):221-222. 被引量:3
-
9田馨,郭雨凡,胡亚会,周鹏飞,魏殿军,崔宇杰,刘运德.抗P-selectin及血小板糖蛋白Ⅱb/Ⅲa抗体检测在特发性血小板减少性紫癜与原发性干燥综合征伴血小板减少鉴别诊断中的意义[J].中国血液流变学杂志,2014,0(4):469-471. 被引量:1
-
10赵赟霄,何杨,朱明清,阮长耿.流式免疫微球芯片技术检测血小板膜糖蛋白特异性自身抗体的方法及其临床应用[J].苏州大学学报(医学版),2012,32(6):826-829. 被引量:1